While tumor-bearing mice with a systemic administration of TGFβ showed no difference with respect to myeloid-derived suppressor cells (MDSCs) or dendritic cells (DCs), both cell types were reduced in liver metastases. The gene discussed is TGFB1; the disease is neoplasm.